The
“Transfusion News” email appeared in
my in-box this morning:
Low Hematocrit and Bleeding Risk for Patients with Hypoproliferative Thrombocytopenia
![]()
September 13, 2017
Prophylactic platelet transfusions are the standard of care for hypoproliferative thrombocytopenia. Over one thousand adult patients (n=1077) enrolled in a multi-center, randomized clinical trial assessing platelet doses in transfusions (PLADO trial) were followed to identify factors that increase the risk of bleeding in patients with hypoproliferative thrombocytopenia. Chemotherapy and stem cell transplant (SCT) patients were [Read More]
Prophylactic platelet transfusions are the standard of care for hypoproliferative thrombocytopenia. Over one thousand adult patients (n=1077) enrolled in a multi-center, randomized clinical trial assessing platelet doses in transfusions (PLADO trial) were followed to identify factors that increase the risk of bleeding in patients with hypoproliferative thrombocytopenia. Chemotherapy and stem cell transplant (SCT) patients were [Read More]
FDA Approves CAR-T Gene Therapy for Acute Lymphoblastic Leukemia
With the FDA approval of the first gene therapy, or a nucleic acid drug, we have entered a new era for fighting diseases. Kymriah was approved on August 30th to treat B-cell acute lymphoblastic leukemia (ALL) in patients 25 years old and younger which have relapsed or not responded to initial treatment. ALL is the [Read More]
| A Quality Management Focus on Competency Assessment
Competent testing personnel is one of the essential parts of a laboratory quality program, however, adequately interpreting and implementing a program can be difficult. Come hear customer experts discuss this topic at AABB 2017 at the Bio-Rad sponsored workshop. [Register]
|
No comments:
Post a Comment